Based on these integrated datasets, our study provides potential evidence for the genetic colocalization of six drug target genes (HP, HLA‐DRA, MAP 3K3, MFGE8, COL15A1, and AURKA) with sarcopenia. The gene discussed is HLA-DRA; the disease is sarcopenia.